Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR
Open Access
- 23 May 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 17 (6), 1051-1057
- https://doi.org/10.1038/sj.leu.2402937
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Quantification of CBFβ/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemiaLeukemia, 2001
- Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoireLeukemia, 2000
- Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myelomaTransplantation and Cellular Therapy, 2000
- Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic CellsJournal of Clinical Oncology, 1999
- Total Therapy With Tandem Transplants for Newly Diagnosed Multiple MyelomaBlood, 1999
- High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical TrialBlood, 1998
- Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvestsBritish Journal of Haematology, 1996
- Circulating Clonotypic B Cells in the Biology of Multiple Myeloma: Speculations on the Origin of MyelomaLeukemia & Lymphoma, 1996
- The human immunoglobulin VH repertoireImmunology Today, 1995
- Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variationBlood, 1992